BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 19667569)

  • 1. Increasing in vitro resistance of E coli to TMP/SMX.
    Postgrad Med; 2001 Aug; 110(2 Suppl):5-8; discussion 26-7. PubMed ID: 19667569
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro resistance of E coli to TMP/SMX and clinical failure.
    Postgrad Med; 2001 Aug; 110(2 Suppl):9-10; discussion 26-7. PubMed ID: 19667570
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical implications. In vitro resistance of E coli to TMP/SMX.
    Postgrad Med; 2001 Aug; 110(2 Suppl):11-5; discussion 26-7. PubMed ID: 19667571
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of clinical guidelines.
    Postgrad Med; 2001 Aug; 110(2 Suppl):16-20; discussion 26-7. PubMed ID: 19667572
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan.
    Brown PD; Freeman A; Foxman B
    Clin Infect Dis; 2002 Apr; 34(8):1061-6. PubMed ID: 11914994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for resistance to "first-line" antimicrobials among urinary tract isolates of Escherichia coli in children.
    Allen UD; MacDonald N; Fuite L; Chan F; Stephens D
    CMAJ; 1999 May; 160(10):1436-40. PubMed ID: 10352632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escherichia coli resistance in uncomplicated urinary tract infection: a model for determining when to change first-line empirical antibiotic choice.
    Perfetto EM; Gondek K
    Manag Care Interface; 2002 Jun; 15(6):35-42. PubMed ID: 12087605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
    Karlowsky JA; Thornsberry C; Jones ME; Sahm DF
    Clin Infect Dis; 2003 Jan; 36(2):183-7. PubMed ID: 12522750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary infections due to multi-drug-resistant Escherichia coli among persons with HIV disease at a tertiary AIDS care centre in South India.
    Vignesh R; Shankar EM; Murugavel KG; Kumarasamy N; Sekar R; Irene P; Solomon S; Balakrishnan P
    Nephron Clin Pract; 2008; 110(1):c55-7. PubMed ID: 18724067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women.
    Beerepoot MA; ter Riet G; Nys S; van der Wal WM; de Borgie CA; de Reijke TM; Prins JM; Koeijers J; Verbon A; Stobberingh E; Geerlings SE
    Arch Intern Med; 2011 Jul; 171(14):1270-8. PubMed ID: 21788542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethoprim in vitro antibacterial activity is not increased by adding sulfamethoxazole for pediatric Escherichia coli urinary tract infection.
    Nguyen HT; Hurwitz RS; Defoor WR; Minevich E; McAdam AJ; Mortensen JE; Novak-Weekley SM; Minnillo BJ; Elder JS
    J Urol; 2010 Jul; 184(1):305-10. PubMed ID: 20488468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: a decision and cost analysis.
    Le TP; Miller LG
    Clin Infect Dis; 2001 Sep; 33(5):615-21. PubMed ID: 11486284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimethoprim/sulfamethoxazole resistance in urinary tract infections.
    Guneysel O; Onur O; Erdede M; Denizbasi A
    J Emerg Med; 2009 May; 36(4):338-41. PubMed ID: 18325714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary tract infection in women over the age of 65: is age alone a marker of complication?
    Grover ML; Bracamonte JD; Kanodia AK; Edwards FD; Weaver AL
    J Am Board Fam Med; 2009; 22(3):266-71. PubMed ID: 19429732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary tract infections and a multidrug-resistant Escherichia coli clonal group.
    Sandel DC; Wang CT; Kessler S
    N Engl J Med; 2002 Feb; 346(7):535-6. PubMed ID: 11844861
    [No Abstract]   [Full Text] [Related]  

  • 16. Addressing antibiotic resistance.
    Gupta K
    Dis Mon; 2003 Feb; 49(2):99-110. PubMed ID: 12601340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance of urinary tract isolates of Escherichia coli to trimethoprim, cotrimoxazole and ampicillin.
    Bailey RR; Peddie BA
    N Z Med J; 1988 Apr; 101(844):216-7. PubMed ID: 3283613
    [No Abstract]   [Full Text] [Related]  

  • 18. Emerging Escherichia coli O25b/ST131 clone predicts treatment failure in urinary tract infections.
    Can F; Azap OK; Seref C; Ispir P; Arslan H; Ergonul O
    Clin Infect Dis; 2015 Feb; 60(4):523-7. PubMed ID: 25378460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens.
    Raz R; Chazan B; Kennes Y; Colodner R; Rottensterich E; Dan M; Lavi I; Stamm W;
    Clin Infect Dis; 2002 May; 34(9):1165-9. PubMed ID: 11941541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten years surveillance of antimicrobial susceptibility of community-acquired Escherichia coli and other uropathogens in northern Israel (1995-2005).
    Rock W; Colodner R; Chazan B; Elias M; Raz R
    Isr Med Assoc J; 2007 Nov; 9(11):803-5. PubMed ID: 18085038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.